News
Precigen To Present Late-Breaking Abstract For Pivotal Phase 2 Study Data For PRGN-2012 AdenoVerse Immunotherapy For The Treatment Of Patients With Recurrent Respiratory Papillomatosis At The 2024 ASCO Annual Meeting
24 Apr 24
Biotech, News, General
JP Morgan Downgrades Precigen to Underweight
22 Mar 24
News, Downgrades, Analyst Ratings
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
21 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
JMP Securities Reiterates Market Outperform on Precigen, Maintains $14 Price Target
20 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Precigen Q4 Earnings
19 Mar 24
Earnings
Precigen Gives Business Updates, Significant Progress Made In The Development Of The PRGN-2012 Adenoverse Immunotherapy For The Treatment Of RRP; Plans To Submit A BLA Under An Accelerated Approval Pathway In 2H Of 2024
19 Mar 24
Biotech, News, General
Preview: Precigen's Earnings
18 Mar 24
Earnings
Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
12 Feb 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Amtech Systems Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
12 Feb 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Press releases
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting
24 Apr 24
Press Releases
Actym Therapeutics Appoints Thomas Smart as CEO
24 Apr 24
Press Releases
Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis
12 Mar 24
Press Releases
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th
5 Mar 24
Press Releases
Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
6 Feb 24
Press Releases